P. Wirth

发表

Regulation of Heparin-Binding EGF-Like Growth Factor by miR-212 and Acquired Cetuximab-Resistance in Head and Neck Squamous Cell Carcinoma

P. Harari, C. Chung, R. Slebos, 2010, PloS one.

Human papillomavirus in early laryngeal carcinoma

C. Meijer, P. Snijders, C. Chung, 2009, The Laryngoscope.

Gastric Graft-Versus-Host Disease Revisited: Does Proton Pump Inhibitor Therapy Affect Endoscopic Gastric Biopsy Interpretation?

K. Washington, P. Wirth, J. Goldenring, 2006, The American journal of surgical pathology.

Comparison of Staining Characteristics of Apoptotic Markers

P. Wirth, S. Olson, 2005 .

Transforming growth factor beta receptor type II inactivation promotes the establishment and progression of colon cancer.

Shiva Gautam, Anna Chytil, Kay Washington, 2004, Cancer Research.

The prognostic potential of the epidermal growth factor receptor and nuclear factor kappa B pathways and associated therapeutic strategies in patients with squamous cell carcinoma of the head and neck

P. Wirth, 2010 .

Imaging mass spectrometry of intact proteins from alcohol-preserved tissue specimens: bypassing formalin fixation.

P. Chaurand, R. Caprioli, P. Wirth, 2008, Journal of proteome research.

Phase 2 trial of oxaliplatin and pemetrexed as an induction regimen in locally advanced head and neck cancer

Christine H Chung, Jill Gilbert, C. Chung, 2012, Cancer.

Human‐in‐mouse modeling of primary head and neck squamous cell carcinoma

J. Netterville, B. Burkey, R. Sinard, 2009, The Laryngoscope.

Cancer Promotes the Establishment and Progression of Colon Receptor Type II Inactivation β Transforming Growth Factor Updated

K. Washington, S. Gautam, H. Moses, 2004 .

Transforming Growth Factor β Receptor Type II Inactivation Promotes the Establishment and Progression of Colon Cancer

K. Washington, S. Gautam, H. Moses, 2004, Cancer Research.